Ahmed Mostafa - Concepedia

Author

Ahmed Mostafa

Memorial University of Newfoundland ORCID

Also Known As

A Mostafa, A. A. Mostafa, A. Mostafa, A.A. Mostafa, Ahmed A Mostafa, Ahmed A. Mostafa, Ahmed Abdullah Mostafa, Ahmed Mostafa, Alyaa Mostafa, K Mahmoud

Publications

570

Citations

H-Index

Concepts

All Affiliations

Memorial University of Newfoundland Calgary Laboratory Services University of Toronto University of Calgary Alberta Children's Hospital

About

Ahmed Mostafa is an author at Memorial University of Newfoundland specializing in medicine, cancer research, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	164
2	Health Sciences	2	2	129
3	Biochemistry	1	1	104
4	Cell Biology	1	1	25
5	Diabetes	1	1	104

Ahmed Mostafa

Publications

412

Citations

H-Index

Page 1

	Year	Citations
Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes Ahmed Mostafa, Edward Randell, Sudesh Vasdev, Molecular and Cellular Biochemistry Metabolic SyndromePlasma ProteinCarboxymethyl CysteineRenal FunctionBiochemistry	2007	104
Activation of ERα Signaling Differentially Modulates IFN-γ Induced HLA-Class II Expression in Breast Cancer Cells Ahmed Mostafa, D. Codner, Kensuke Hirasawa, PLoS ONE	2014	82
Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer Ahmed Mostafa, Daniel E. Meyers, Chandini M. Thirukkumaran, Cancers	2018	61
Comparison of sequence‐specific oligonucleotide probe vs next generation sequencing for HLA‐A, B, C, DRB1, DRB3/B4/B5, DQA1, DQB1, DPA1, and DPB1 typing: Toward single‐pass high‐resolution HLA typing in support of solid organ and hematopoietic cell transplant programs Anajane G. Smith, Shalini Pereira, Andrés Jaramillo, HLA	2019	47
Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma Keith A. Lawson, Ahmed Mostafa, Zhong Qiao Shi, Clinical Cancer Research ImmunologyImmunoeditingImmunotherapeuticsAntiviral DrugImmunotherapy	2016	35
Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model Chandini M. Thirukkumaran, Zhong Qiao Shi, Gerard J. Nuovo, Blood Advances ImmunologyImmunoeditingImmunotherapyBortezomib SynergyTumor Biology	2019	25
Private rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritis Darren D. O’Rielly, Mohammed Uddin, D. Codner, Annals of the Rheumatic Diseases	2015	18
Novel alleles in the era of next-generation sequencing-based HLA typing calls for standardization and policy Jenny Tran, Karen Sherwood, Ahmed Mostafa, Frontiers in Genetics	2023	16
A pathogenic deletion in Forkhead Box L1 (FOXL1) identifies the first otosclerosis (OTSC) gene Nelly Abdelfatah, Ahmed Mostafa, Curtis R. French, Human Genetics	2021	14
The role of the HLA allelic repertoire on the clinical severity of COVID-19 in Canadians, living in the Saskatchewan province Pramath Kakodkar, Pouneh Dokouhaki, Fang‐Xiang Wu, Human Immunology	2023	10

Page 1